Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
2000 1
2001 1
2002 1
2003 1
2006 1
2008 2
2010 1
2011 4
2014 1
2015 2
2016 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean epaxial bern (1 results)?
Biophysical validation of Epaxal Berna, a hepatitis A vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes (IRIV).
Glück R, Wälti E. Glück R, et al. Dev Biol (Basel). 2000;103:189-97. Dev Biol (Basel). 2000. PMID: 11214236 Review.
For a new influenza vaccine the surface spikes (HA and NA) of three currently circulating influenza strains were jointly inserted into the vesicle membrane of the IRIVs and successfully tested clinically. In Epaxal Berna, the first commercially available liposomal v …
For a new influenza vaccine the surface spikes (HA and NA) of three currently circulating influenza strains were jointly inserted into the v …
Intranasal immunization against influenza.
Glück R. Glück R. J Aerosol Med. 2002 Summer;15(2):221-8. doi: 10.1089/089426802320282347. J Aerosol Med. 2002. PMID: 12184872 Review.
Nasalflu is based on the virosomal concept which is registered in the EU as Epaxal Berna, a vaccine against Hepatitis A, and Inflexal Berna V, a subunit influenza vaccine. ...
Nasalflu is based on the virosomal concept which is registered in the EU as Epaxal Berna, a vaccine against Hepatitis A, and I …
Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
D'Acremont V, Herzog C, Genton B. D'Acremont V, et al. J Travel Med. 2006 Mar-Apr;13(2):78-83. doi: 10.1111/j.1708-8305.2006.00001.x. J Travel Med. 2006. PMID: 16553593 Free article. Clinical Trial.

METHODS: In this open, uncontrolled study, subjects of 18 to 45 years or < or = 50 years of age received two doses of aluminum-free, virosomal HAV vaccine, Epaxal (Berna Biotech Ltd, formerly Swiss Serum and Vaccine Institute, Bern, Switzerland) 12 months apart.

…

METHODS: In this open, uncontrolled study, subjects of 18 to 45 years or < or = 50 years of age received two doses of aluminum-free, viro

…
[Immunogenicity and stability of an aluminum-free liposomal hepatitis A vaccine (Epaxal Berna)].
Wegmann A, Zellmeyer M, Glück R, Finkel B, Flückiger A, Berger R, Just M. Wegmann A, et al. Schweiz Med Wochenschr. 1994 Nov 12;124(45):2053-6. Schweiz Med Wochenschr. 1994. PMID: 7973542 German.
The high immunogenicity of the liposomal hepatitis A vaccine (Epaxal Berna) after a single dose and after a booster dose one year later has been confirmed in several studies with healthy adult volunteers: 95-100% and 96-100% seroconversion (> or = 20 mIE/ml) afte …
The high immunogenicity of the liposomal hepatitis A vaccine (Epaxal Berna) after a single dose and after a booster dose one y …
19 results